Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
Absent, added, afforded, agonist, Amnesteemtm, annum, answered, appellate, await, awaiting, belief, bond, Bulletin, buyback, Canada, carbidopa, central, Cephalon, chloride, closure, collaborate, collaboration, collaborative, confidential, consummated, contributor, copyand, DEA, disclosed, Ditropan, drawn, Dutch, eligible, EMSAM®Approval, excessive, fall, fee, fixed, flexibility, flow, foreseeable, Forest, Hawaii, indemnity, indenture, inflated, involuntary, IRC, IRS, jointly, junior, jury, landscape, Lastly, led, levodopa, LIBOR, lien, loan, mandatory, merge, Minnesota, Mississippi, Missouri, narcotic, observed, opportunity, outlicensing, oxybutynin, pain, parent, passed, penalty, persuasive, pledge, power, prepayment, prime, priority, procurement, quota, rank, ratio, recast, Reclassification, rectified, redirect, refinance, refusal, repayment, resolution, restructuring, reverted, SAB, satisfactory, sector, semiannually, senior, sooner, standard, stop, storage, succeed, suggested, survived, Task, tender, tendered, tendering, turn, twelve, unamortized, unconditional, unpaid, unused, upfront, upheld, Usage, USW, verdict, vulnerable, willfully, withstand, XL
Removed:
bioequivalency, Biovail, borrow, Buspar, buspirone, cardiology, carried, Compensationand, core, daily, dermatology, Digitek, discretion, efficient, Eldepryl, emphasize, equally, equitable, finalized, insure, Interbank, invest, irrevocable, lender, London, neurology, Northern, notice, overlap, Parkinson, partnership, Penederm, petition, Pfizer, phenytoin, prescriber, presence, principle, professional, putative, reaching, renewed, servicing, settled, stable, Taxol, therapeutically, unclear, unrelated, utilized, voluntarily
Filing tables
Filing exhibits
- 10-K Annual report
- 10.4 EX-10.4.D
- 10.4 EX-10.4.E
- 10.5 EX-10.5
- 10.6 EX-10.6.B
- 10.7 EX-10.7.B
- 10.8 EX-10.8.B
- 10.9 EX-10.9.B
- 10.10 EX-10.10.B
- 10.11 EX-10.11.B
- 10.12 EX.10.12.B
- 10.13 EX-10.13.B
- 10.14 EX-10.14.B
- 10.15 EX-10.15.B
- 10.19 EX-10.19.C
- 10.20 EX-10.20.C
- 10.21 EX-10.21.C
- 10.22 EX-10.22.C
- 10.23 EX-10.23
- 10.24 EX-10.24.B
- 21 EX-21
- 23 EX-23
- 31.1 EX-31.1
- 31.2 EX-31.2
- 32 EX-32
Related press release
Mylan similar filings
Filing view
External links
EXHIBIT 21
Subsidiaries
Name | State of Organization | |
Mylan Pharmaceuticals Inc. | West Virginia | |
Milan Holding Inc. | Vermont | |
Mylan Bertek Pharmaceuticals Inc. | Texas | |
Mylan Inc. | Delaware | |
UDL Laboratories, Inc. | Illinois | |
Mylan Technologies Inc. | West Virginia | |
American Triumvirate Insurance Company | Vermont | |
Mylan International Holdings, Inc. | Vermont | |
Mylan Caribe, Inc. | Vermont | |
MLRE LLC | Pennsylvania |
74